FDA announces first US gene therapy approval for cancer treatment

WASHINGTON D.C. — The US Food and Drug Administration approved a new leukemia treatment, which the agency considers the first gene therapy it has cleared to hit the market in the United States. The treatment, called Kymriah, aims to give some patients a second chance after first-line drugs have failed. This may happen in up to a fifth of patients, according to the FDA. Each dose of Kymriah contains a patient’s own immune cells, which are sent to a lab […]